Metformin Suppresses Prostaglandin E2-Induced Cytochrome P450 Aromatase Gene Expression and Activity via Stimulation of AMP-Activated Protein Kinase in Human Endometriotic Stromal Cells
Restricted accessResearch articleFirst published online September, 2015
Metformin Suppresses Prostaglandin E2-Induced Cytochrome P450 Aromatase Gene Expression and Activity via Stimulation of AMP-Activated Protein Kinase in Human Endometriotic Stromal Cells
Cytochrome P450 aromatase (encoded by the CYP19A1/aromatase gene) plays a critical physiologic role in endometriosis. Metformin is known to suppress prostaglandin E2 (PGE2)-induced CYP19A1 messenger RNA (mRNA) expression in human endometriotic stromal cells (ESCs). However, the possible mechanism behind this suppression remains to be determined.
Methods:
In this study, ESCs were cultured with metformin, PGE2, and adenosine monophosphate (AMP)-activated protein kinase (AMPK) inhibitors. Expression of CYP19A1 mRNA and aromatase activity were measured by quantitative polymerase chain reaction and aromatase activity assay, respectively. The binding of the cyclic AMP response element-binding (CREB) protein to CYP19A1 promoter II (PII) was assessed by chromatin immunoprecipitation assay.
Results:
We demonstrated that metformin downregulated the expression of aromatase mRNA (32%) and activity (25%) stimulated by PGE2 (4.18-fold and 2.14-fold) in ESCs via stimulation of AMPK. Following PGE2 treatment, there was a marked increase in CREB binding to aromatase PII, while metformin attenuated the above-mentioned stimulation by 67%.
Conclusion:
Metformin could inhibit PGE2-induced CYP19A1 mRNA expression and aromatase activity via AMPK activation and inhibition of CREB to CYP19A1 PII in human ESCs. The results of the present study suggest that metformin may have unique therapeutic potential as an antiendometriotic drug in the future.
OliveDLSchwartzLB. Endometriosis. N Engl J Med. 1993;328(24):1759–1769.
2.
RyanIPTaylorRN. Endometriosis and infertility: new concepts. Obstet Gynecol Surv. 1997;52(6):365–371.
3.
KitawakiJNoguchiTAmatsuT. Expression of aromatase cytochrome P450 protein and messenger ribonucleic acid in human endometriotic and adenomyotic tissues but not in normal endometrium. Biol Reprod. 1997;57(3):514–519.
4.
ZeitounKTakayamaKMichaelMDBulunSE. Stimulation of aromatase P450 promoter (II) activity in endometriosis and its inhibition in endometrium are regulated by competitive binding of steroidogenic factor-1 and chicken ovalbumin upstream promoter transcription factor to the same cis-acting element. Mol Endocrinol. 1999;13(2):239–253.
5.
BulunSEYangSFangZ. Role of aromatase in endometrial disease. J Steroid Biochem Mol Biol. 2001;79(1–5):19–25.
6.
FangZYangSGuratesB. Genetic or enzymatic disruption of aromatase inhibits the growth of ectopic uterine tissue. J Clin Endocrinol Metab. 2002;87(7):3460–3466.
7.
AttarEBulunSE. Aromatase and other steroidogenic genes in endometriosis: translational aspects. Hum Reprod Update. 2006;12(1):49–56.
8.
SebastianSBulunSE. A highly complex organization of the regulatory region of the human CYP19 (aromatase) gene revealed by the Human Genome Project. J Clin Endocrinol Metab. 2001;86(10):4600–4602.
BulunSELinZImirG. Regulation of aromatase expression in estrogen-responsive breast and uterine disease: from bench to treatment. Pharmacol Rev. 2005;57(3):359–383.
11.
SimpsonERMahendrooMSMeansGD. Aromatase cytochrome P450, the enzyme responsible for estrogen biosynthesis. Endocr Rev. 1994;15(3):342–355.
12.
SunHSHsiaoKYHsuCCWuMHTsaiSJ. Transactivation of steroidogenic acute regulatory protein in human endometriotic stromalcells is mediated by the prostaglandin EP2 receptor. Endocrinology. 2003;144(9):3934–3942.
13.
MichaelMDMichaelLFSimpsonER. A CRE-like sequence that binds CREB and contributes to cAMP-dependent regulation of the proximal promoter of the human aromatase P450 (CYP19) gene. Mol Cell Endocrinol. 1997;134(2):147–156.
14.
HinshelwoodMMMichaelMDSimpsonER. The 5′-flanking region of the ovarian promoter of the bovine CYP19 gene contains a deletion in a cyclic adenosine 3′,5′-monophosphate-like responsive sequence. Endocrinology. 1997;138(9):3704–3710.
IsodaKYoungJLZirlikA. Metformin inhibits proinflammatory responses and nuclear factor-kappaB in human vascular wall cells. Arterioscler Thromb Vasc Biol. 2006;26(3):611–617.
19.
AttiaGRRaineyWECarrBR. Metformin directly inhibits androgen production in human thecal cells. Fertil Steril. 2001;76(3):517–524.
20.
MansfieldRGaleaRBrincatMHoleDMasonH. Metformin has direct effects on human ovarian steroidogenesis. Fertil Steril. 2003;79(4):956–962.
21.
OnerGOzcelikBOzgunMTSerinISOzturkFBasbugM. The effects of metformin and letrozole on endometriosis and comparison of the two treatment agents in a rat model. Hum Reprod. 2010;25(4):932–937.
22.
ZhouGMyersRLiY. Role of AMP-activated protein kinase in mechanism of metformin action. J Clin Invest. 2001;108(8):1167–1174.
23.
KahnBBAlquierTCarlingDHardieDG. AMP-activated protein kinase: ancient energy gauge provides clues to modern understanding of metabolism. Cell Metab. 2005;1(1):15–25.
24.
HardieDG. The AMP-activated protein kinase pathway—new players upstream and downstream. J Cell Sci. 2004;117(pt 23):5479–5487.
25.
XuJNZengCZhouYPengCZhouYFXueQ. Metformin inhibits StAR expression in human endometrial stromal cells via AMPK-mediated disruption of CREB-CRTC2 complex formation. J Clin Endocrinol Metab. 2014;99(8):2795–2803.
26.
RiceSPellattLRamanathanKWhiteheadSAMasonHD. Metformin inhibits aromatase via an extracellular signal-regulated kinase-mediated pathway. Endocrinology. 2009;150(10):4794–4801.
27.
RyanIPSchriockEDTaylorRN. Isolation, characterization, and comparison of human endometrial and endometriosis cells in vitro. J Clin Endocrinol Metab. 1994;78(3):642–649.
28.
LivakKJSchmittgenTDAgarwalVRZhaoYCarrBRBulunSE. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001;25(4):402–408.
29.
DebSZhouJAminSA. A novel role of sodium butyrate in the regulation of cancer-associated aromatase promoters I.3 and II by disrupting a transcriptional complex in breast adipose fibroblasts. J Biol Chem. 2006;281(5):2585–2597.
30.
RiceSEliaAJawadZPellattLMasonHD. Metformin inhibits follicle-stimulating hormone (FSH) action in human granulosa cells: relevance to polycystic ovary syndrome. J Clin Endocrinol Metab. 2013;98(9):E1491–E1500.
31.
PavoneMEBulunSE. Aromatase inhibitors for the treatment of endometriosis. Fertil Steril. 2012;98(6):1370–1379.
32.
BulunSE. Endometriosis. N Engl J Med. 2009;360(3):268–279.
33.
AttarETokunagaHImirG. Prostaglandin E2 via steroidogenic factor-1 coordinately regulates transcription of steroidogenic genes necessary for estrogen synthesis in endometriosis. J Clin Endocrinol Metab. 2009;94(2):623–631.
34.
NobleLSSimpsonERJohnsABulunSE. Aromatase expression in endometriosis. J Clin Endocrinol Metab. 1996;81(1):174–179.
35.
PurohitAFusiLBrosensJWooLWPotterBVReedMJ. Inhibition of steroid sulphatase activity in endometriotic implants by 667 COUMATE: a potential new therapy. Hum Reprod. 2008;23(2):290–297.
36.
MaiaHJrHaddadCCasoyJ. Correlation between aromatase expression in the eutopic endometrium of symptomatic patients and the presence of endometriosis. Int J Womens Health. 2012;4:61–65.
37.
ColetteSLousseJCDefrereS. Absence of aromatase protein and mRNA expression in endometriosis. Hum Reprod. Sep;24(9):2133–2141.
38.
DelvouxBGroothuisPD’HoogheTKyamaCDunselmanGRomanoA. Increased production of 17beta-estradiol in endometriosis lesions is the result of impaired metabolism. J Clin Endocrinol Metab. 32009;94(3):876–883.
39.
FerreroSRemorgidaVMaganzaC. Aromatase and endometriosis: estrogens play a role. Ann N Y Acad Sci. 52014;1317:17–23.
40.
BulunSEUtsunomiyaHLinZ. Steroidogenic factor-1 and endometriosis. Mol Cell Endocrinol. 352009;300(1–2):104–108.
41.
TakemuraYOsugaYYoshinoO. Metformin suppresses interleukin (IL)-1beta-induced IL-8 production, aromatase activation, and proliferation of endometriotic stromal cells. J Clin Endocrinol Metab. 82007;92(8):3213–3218.
42.
BrownKAHungerNIDocantoMSimpsonER. Metformin inhibits aromatase expression in human breast adipose stromal cells via stimulation of AMP-activated protein kinase. Breast Cancer Res Treat. 2010;123(2):591–596.
43.
KolaBBoscaroMRutterGAGrossmanABKorbonitsM. Expanding role of AMPK in endocrinology. Trends Endocrinol Metab. 2006;17(5):205–215.
44.
ToscaLSolnaisPFerrePFoufelleFDupontJ. Metformin-induced stimulation of adenosine 5′-monophosphate-activated protein kinase (PRKA) impairs progesterone secretion in rat granulosa cells. Biol Reprod. 2006;75(3):342–351.
45.
ToscaLChabrolleCUzbekovaSDupontJ. Effects of metformin on bovine granulosa cells steroidogenesis: possible involvement of adenosine 5′-monophosphate-activated protein kinase (AMPK). Biol Reprod. 2007;76(3):368–378.
46.
ToscaLUzbekovaSChabrolleCDupontJ. Possible role of 5′AMP-activated protein kinase in the metformin-mediated arrest of bovine oocytes at the germinal vesicle stage during in vitro maturation. Biol Reprod. 2007;77(3):452–465.
47.
BrownKAMcInnesKJHungerNIOakhillJSSteinbergGRSimpsonER. Subcellular localization of cyclic AMP-responsive element binding protein-regulated transcription coactivator 2 provides a link between obesity and breast cancer in postmenopausal women. Cancer Res. 2009;69(13):5392–5399.
48.
TakemuraYOsugaYHaradaM. Serum adiponectin concentrations are decreased in women with endometriosis. Hum Reprod. 2005;20(12):3510–3513.
49.
TakemuraYOsugaYHaradaM. Concentration of adiponectin in peritoneal fluid is decreased in women with endometriosis. Am J Reprod Immunol. 2005;54(4):217–221.
50.
TakemuraYOsugaYYamauchiT. Expression of adiponectin receptors and its possible implication in the human endometrium. Endocrinology. 2006;147(7):3203–3210.
51.
MannaPRChandralaSPKingSR. Molecular mechanisms of insulin-like growth factor-I mediated regulation of the steroidogenic acute regulatory protein in mouse leydig cells. Mol Endocrinol. 2006;20(2):362–378.
52.
MartinelleNHolstMSoderOSvechnikovK. Extracellular signal-regulated kinases are involved in the acute activation of steroidogenesis in immature rat Leydig cells by human chorionic gonadotropin. Endocrinology. 2004;145(10):4629–4634.
53.
EatonJLUnnoKCaraveoMLuZKimJJ. Increased AKT or MEK1/2 activity influences progesterone receptor levels and localization in endometriosis. J Clin Endocrinol Metab. 2013;98(12):E1871–E1879.
54.
SirianniRChimentoAMalivindiRMazzitelliIAndoSPezziV. Insulin-like growth factor-I, regulating aromatase expression through steroidogenic factor 1, supports estrogen-dependent tumor Leydig cell proliferation. Cancer Res. 2007;67(17):8368–8377.
55.
Hunzicker-DunnMMaizelsET. FSH signaling pathways in immature granulosa cells that regulate target gene expression: branching out from protein kinase A. Cell Signal. 2006;18(9):1351–1359.
56.
ConkrightMDCanettieriGScreatonR. TORCs: transducers of regulated CREB activity. Mol Cell. 2003;12(2):413–423.
57.
IourgenkoVZhangWMickaninC. Identification of a family of cAMP response element-binding protein coactivators by genome-scale functional analysis in mammalian cells. Proc Natl Acad Sci U S A. 2003;100(21):12147–12152.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
